Wegovy vs Saxenda: Price & Results Breakdown (2026)
Trying to choose between Wegovy (Semaglutide) and Saxenda (Liraglutide)? Below we put the trial weight loss numbers, monthly cost, dosing, and tolerability head to head — and spell out the type of patient each one tends to fit best.
Wegovy (Semaglutide) and Saxenda (Liraglutide) both work as GLP-1 receptor agonists but differ in formulation and dosing. Wegovy is FDA-approved for chronic weight management and cardiovascular risk reduction, while Saxenda is approved for chronic weight management. Average weight loss: 15-17% of body weight (Wegovy) vs 5-8% of body weight (Saxenda).
The Numbers at a Glance
| Feature | Wegovy | Saxenda |
|---|---|---|
| Active Ingredient | Semaglutide | Liraglutide |
| Mechanism | GLP-1 receptor agonist | GLP-1 receptor agonist |
| FDA Approved For | Chronic weight management, Cardiovascular risk reduction | Chronic weight management |
| Doses | 0.25mg to 2.4mg (weekly injection), oral pill available | 0.6mg to 3mg (daily injection) |
| Administration | Weekly subcutaneous injection or daily oral pill | Daily subcutaneous injection |
| Avg. Weight Loss | 15-17% of body weight | 5-8% of body weight |
| Monthly Price | $1,349 | $1,350 |
| Oral Available | Yes | No |
| Year Approved | 2021 | 2014 |
- Wegovy
- Semaglutide
- Saxenda
- Liraglutide
- Wegovy
- GLP-1 receptor agonist
- Saxenda
- GLP-1 receptor agonist
- Wegovy
- Chronic weight management, Cardiovascular risk reduction
- Saxenda
- Chronic weight management
- Wegovy
- 0.25mg to 2.4mg (weekly injection), oral pill available
- Saxenda
- 0.6mg to 3mg (daily injection)
- Wegovy
- Weekly subcutaneous injection or daily oral pill
- Saxenda
- Daily subcutaneous injection
- Wegovy
- 15-17% of body weight
- Saxenda
- 5-8% of body weight
- Wegovy
- $1,349
- Saxenda
- $1,350
- Wegovy
- Yes
- Saxenda
- No
- Wegovy
- 2021
- Saxenda
- 2014
Figures shown are typical cash-pay prices before insurance. What you pay can differ by pharmacy, region, and your specific plan. Last updated March 2026.
Which Drops More Weight?
Based on clinical data, Wegovy produces more weight loss on average (15-17% of body weight) compared to Saxenda (5-8% of body weight). They act on the body in much the same way, but formulation and dosing differences nudge the results apart.
Carries an FDA indication dedicated to long-term weight management. It delivers semaglutide at a stronger dose than Ozempic, and a pill version became available in January 2026.
Among the earliest GLP-1 therapies to win FDA clearance for weight loss. It calls for a shot every day, unlike the weekly schedule of newer drugs, and is steadily giving way to more potent alternatives.
Which Is Easier on Your Wallet?
At list price, Wegovy is the more affordable option at $1,349/month compared to $1,350/month for Saxenda. That said, what leaves your pocket swings hugely with your coverage. Wegovy with insurance: $25-$200/month typical copay. Saxenda with insurance: Varies widely.
Tablet form starts at $149/month for the entry dose (released Jan 2026)
A manufacturer savings card is available
How the Side Effects Stack Up
Wegovy (GLP-1 receptor agonist) and Saxenda (GLP-1 receptor agonist) bring on much the same digestive side effects, which top the list of what patients report:
- Nausea (most common for both medications)
- Diarrhea and vomiting
- Constipation
- Abdominal pain
- Decreased appetite
- Headache, fatigue, dizziness (less common)
Rarer but more serious risks for both drugs include pancreatitis, gallbladder complications, and kidney strain. Each also carries a boxed warning about medullary thyroid carcinoma seen in rodent studies. Go over your complete medical history with a clinician before you start either one.
So Which One Is Right for You?
There is no single winner — the right pick comes down to your diagnosis, what your plan covers, how much weight you want to lose, and how you feel about injections versus pills. Use the quick checklist below as a starting point:
- -Your primary goal is weight loss (FDA-approved indication)
- -You prefer an oral option over injections
- -You prefer a daily dosing routine
- -Your primary goal is weight loss (FDA-approved indication)
- -You prefer a daily dosing routine
- -Your doctor recommends Liraglutide based on your health profile
See Who Prescribes These at the Lowest Price
Browse vetted telehealth programs that can prescribe Wegovy, Saxenda, and other FDA-approved GLP-1 medications — ranked by what you will actually pay.
Common Questions, Answered
Can I switch from Wegovy to Saxenda?
It can be done, but only under a prescriber's guidance, since Wegovy and Saxenda rely on different active ingredients (Semaglutide vs Liraglutide). Your clinician will set the right starting dose and titration plan for whichever medication you move to.
Which is better for weight loss: Wegovy or Saxenda?
Clinical data suggests Wegovy produces more weight loss on average (15-17% of body weight) compared to Saxenda (5-8% of body weight). However, individual results vary significantly based on dosing, diet, exercise, and metabolic factors.
Is Wegovy cheaper than Saxenda?
At list price, Wegovy ($1,349/month) is less expensive than Saxenda ($1,350/month). With insurance, costs vary significantly. Wegovy: $25-$200/month typical copay. Saxenda: Varies widely.
Do Wegovy and Saxenda have the same side effects?
They overlap a lot. Stomach-related effects like nausea, diarrhea, vomiting, and constipation show up with both because they are typical of GLP-1 receptor agonists. That said, the different active ingredients mean how often and how strongly they hit can differ — talk through your history with a clinician to see which is the safer fit for you.
Does insurance cover Wegovy and Saxenda?
Coverage varies by plan. Wegovy is FDA-approved for chronic weight management and cardiovascular risk reduction — insurance coverage is typically better for on-label use. Saxenda is FDA-approved for chronic weight management. Check with your specific insurance plan and ask your doctor about prior authorization requirements.